ArticlePloS one2016

Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.

Minqian Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.